Cargando…

Management of fracture risk in CKD—traditional and novel approaches

The coexistence of osteoporosis and chronic kidney disease (CKD) is an evolving healthcare challenge in the face of increasingly aging populations. Globally, accelerating fracture incidence causes disability, impaired quality of life and increased mortality. Consequently, several novel diagnostic an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haarhaus, Mathias, Aaltonen, Louise, Cejka, Daniel, Cozzolino, Mario, de Jong, Renate T, D'Haese, Patrick, Evenepoel, Pieter, Lafage-Proust, Marie-Hélène, Mazzaferro, Sandro, McCloskey, Eugene, Salam, Syazrah, Skou Jørgensen, Hanne, Vervloet, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	CKJ Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972845/ https://www.ncbi.nlm.nih.gov/pubmed/36865010 http://dx.doi.org/10.1093/ckj/sfac230

Ejemplares similares

MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease
por: Smout, Dieter, et al.
Publicado: (2022)

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?
por: Vervloet, Marc G
Publicado: (2023)

The emerging role of iron in heart failure and vascular calcification in CKD
por: Ciceri, Paola, et al.
Publicado: (2020)

The renal patient seen by non-renal physicians: the kidney embedded in the ‘milieu intérieur’
por: Perez-Villa, Felix, et al.
Publicado: (2020)

Response to Letter to the Editor From Sumi et al: “Lower Bone Turnover and Skeletal PTH Responsiveness in Japanese Compared to European Patients Receiving Hemodialysis”
por: Jørgensen, Hanne Skou, et al.
Publicado: (2022)

Leukocyte–endothelial interaction in CKD
por: Sarakpi, Tamim, et al.
Publicado: (2023)

Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)

Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?
por: Leoncini, Giovanna, et al.
Publicado: (2022)

The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients
por: Zoccali, Carmine, et al.
Publicado: (2023)

Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective
por: Torreggiani, Massimo, et al.
Publicado: (2022)

Unmet needs in clinical trials in CKD: questions we have not answered and answers we have not questioned
por: Levin, Adeera, et al.
Publicado: (2022)

The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors
por: Locatelli, Francesco, et al.
Publicado: (2023)

Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients
por: Hafez, Gaye, et al.
Publicado: (2023)

Contemporary kidney transplantation has a limited impact on bone microarchitecture
por: Meng, Catarina, et al.
Publicado: (2022)

Citation classics: ranking of the top 100 most cited articles in nephrology
por: Montinaro, Vincenzo, et al.
Publicado: (2018)

The new Clinical Kidney Journal, 4 years later
por: Ortiz, Alberto, et al.
Publicado: (2019)

Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
por: Huybrechts, Yentl, et al.
Publicado: (2023)

COVID-19 pandemic era: is it time to promote home dialysis and peritoneal dialysis?
por: Cozzolino, Mario, et al.
Publicado: (2021)

Early aging and premature vascular aging in chronic kidney disease
por: Tanriover, Cem, et al.
Publicado: (2023)

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
por: Behets, Geert J., et al.
Publicado: (2017)

Parathyroidectomy Versus Calcimimetic: The Lower the PTH the Better?
por: Evenepoel, Pieter, et al.
Publicado: (2022)

Evidence in chronic kidney disease–mineral and bone disorder guidelines: is it time to treat or time to wait?
por: Bover, Jordi, et al.
Publicado: (2020)

Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
por: Sarafidis, Pantelis, et al.
Publicado: (2023)

A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community
por: Sever, Mehmet Şükrü, et al.
Publicado: (2020)

Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion
por: Giannini, Sandro, et al.
Publicado: (2017)

Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism
por: Fusaro, Maria, et al.
Publicado: (2022)

Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy
por: Infante, Barbara, et al.
Publicado: (2020)

The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies
por: Tziastoudi, Maria, et al.
Publicado: (2020)

Coronavirus disease 2019 in chronic kidney disease
por: D’Marco, Luis, et al.
Publicado: (2020)

Bone mineral density and mortality in end-stage renal disease patients
por: Iseri, Ken, et al.
Publicado: (2020)

A brand-new cardiorenal syndrome in the COVID-19 setting
por: Apetrii, Mugurel, et al.
Publicado: (2020)

Opportunities in the cloud or pie in the sky? Current status and future perspectives of telemedicine in nephrology
por: Stauss, Madelena, et al.
Publicado: (2020)

Sweet dreams: therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy
por: Afsar, Baris, et al.
Publicado: (2020)

Are endourological procedures for nephrolithiasis treatment associated with renal injury? A review of potential mechanisms and novel diagnostic indexes
por: Mykoniatis, Ioannis, et al.
Publicado: (2020)

An introduction to joint models—applications in nephrology
por: Chesnaye, Nicholas C, et al.
Publicado: (2020)

Acute kidney injury and adverse outcomes of critical illness: correlation or causation?
por: Girling, Benedict J, et al.
Publicado: (2019)

A new series of advanced-level research methods papers
por: Jager, Kitty J, et al.
Publicado: (2020)

Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers
por: Jacobs-Cachá, Conxita, et al.
Publicado: (2020)

Acute kidney injury pathology and pathophysiology: a retrospective review
por: Gaut, Joseph P, et al.
Publicado: (2020)

Evaluation of the Oxford classification in immunoglobulin A vasculitis with nephritis: a cohort study and meta-analysis
por: Yu, Bingxin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kqi2t07kgtu7j6to79edeniba4